Sahlgrenskasjukhuset

Gothenburg 41345

1 studies enrolling now · 8 studies all time

What they study most

Coronary Artery Disease, Coronary Disease, Coronary Restenosis, Diffuse Large B-Cell Lymphoma, Esophageal Squamous Cell Carcinoma, Follicular Lymphoma, Multiple Sclerosis, Multiple Sclerosis (MS), Refractory Generalized Myasthenia Gravis, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) — Recruiting now
• Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) — Running, not enrolling
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) — Completed
• Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS) — Completed
• Oral Cladribine in Early Multiple Sclerosis (MS) — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Completed